Techniques: Parallel, cell-based shRNA and CRISPR screening to predict on- and off-targets of drug compounds

Assays and screens

TECHNOLOGY: Cellular assays

Parallel shRNA- and CRISPR-based screening in human cells could help identify the on- and off-targets of drug compounds. The

Read the full 245 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE